Reply to Martelli et al.: eHealth in Cystic Fibrosis: Promising, but Proof of Concept Is Still Needed

Noah Lechtzin¹, Nicole Mayer-Hamblett^{2

3}, Umer Khan³, Christopher H Goss^{2

3}

Affiliations

Comment

Noah Lechtzin et al. Am J Respir Crit Care Med. 2018.

. 2018 Jul 15;198(2):285-286.

doi: 10.1164/rccm.201803-0481LE.

Noah Lechtzin¹, Nicole Mayer-Hamblett^{2

3}, Umer Khan³, Christopher H Goss^{2

3}

No abstract available

Comment on

Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.
Lechtzin N, Mayer-Hamblett N, West NE, Allgood S, Wilhelm E, Khan U, Aitken ML, Ramsey BW, Boyle MP, Mogayzel PJ Jr, Gibson RL, Orenstein D, Milla C, Clancy JP, Antony V, Goss CH; eICE Study Team. Lechtzin N, et al. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1144-1151. doi: 10.1164/rccm.201610-2172OC. Am J Respir Crit Care Med. 2017. PMID: 28608719 Free PMC article. Clinical Trial.
eHealth in Cystic Fibrosis: Promising, but Proof of Concept Is Still Needed.
Martelli V, Stanbrook M, Anand A. Martelli V, et al. Am J Respir Crit Care Med. 2018 Jul 15;198(2):284-285. doi: 10.1164/rccm.201802-0246LE. Am J Respir Crit Care Med. 2018. PMID: 29698613 No abstract available.

1. Lechtzin N, Mayer-Hamblett N, West NE, Allgood S, Wilhelm E, Khan U, et al. eICE Study Team. Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results. Am J Respir Crit Care Med. 2017;196:1144–1151. - PMC - PubMed
1. Lechtzin N, Merlo C, Meade J, Podliska M, Watts S, Boyle M. Home FEV1 monitoring to assess response to therapy in adults with cystic fibrosis. Pediatr Pulmonol. 2007;42(S30):A379.
1. Bell ML, Fairclough DL. Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Stat Methods Med Res. 2014;23:440–459. - PubMed
1. Lechtzin NA, Kahn S, Hamblett U, Wilhelm NM, West E, Howe NE, et al. The effect of home spirometry and symptom monitoring on treatment adherence in CF. Pediatr Pulmonol. 2015;50(S41):A628.
1. Heltshe SL, West NE, VanDevanter DR, Sanders DB, Beckett VV, Flume PA, et al. STOP Study Group. Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): a trial to compare intravenous antibiotic treatment durations in CF. Contemp Clin Trials. 2018;64:35–40. - PMC - PubMed